Skip to main content

NewsorgaDaily brief

2026-05-11All stories Headlines Search Latest

Tagged

Oncolytic virotherapy

Articles sharing this topic tag. Newest first.

1 story indexed

2026-05-11

1 story

Clinical healthcare facility interior — illustrative imagery for Newsorga's careful explainer on Russia's experimental cancer treatment EnteroMix, an oncolytic virotherapy using four live replication-competent human enteroviruses including Coxsackievirus A21, Echovirus 7, Enterovirus B75 and a Sabin-derived modified poliovirus PV-Russo, still in Phase I clinical trials and the subject of unconfirmed media reports in early May 2026 that China is preparing regulatory approval through its National Medical Products Administration.

Health

Russia's EnteroMix and China's approval rumour: what's true, what isn't

2026-05-119 min read